Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Hungarian drugmaker Richter signed a contract with the European Investment Bank (EIB) on a €150 million credit line to finance research.
The credit line will be used to finance original research in 2011-2014 targeting compounds to treat diseases of the central nervous system combined with biosimilar products, Richter said.
The total amount of the credit facility is to be called down in several tranches within 18 months from the signing of the agreement.
The credit line has a nine-year term, including an initial three-year grace period.